0000899243-19-030004.txt : 20191223 0000899243-19-030004.hdr.sgml : 20191223 20191223190806 ACCESSION NUMBER: 0000899243-19-030004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ray Nitya G. CENTRAL INDEX KEY: 0001709522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 191307703 MAIL ADDRESS: STREET 1: 14 BAYBURY COURT CITY: EAST HANOVER STATE: NJ ZIP: 07936 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-19 0 0001175680 CytoDyn Inc. CYDY 0001709522 Ray Nitya G. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 See Remarks Stock Option (right to buy) 0.63 2019-12-19 4 A 0 600000 0.00 A 2029-12-19 Common Stock 600000 600000 D 200,000 options vest immediately upon grant and 400,000 options will vest upon the achievement of certain additional strategic milestones specified in the award agreement. Chief Technology Officer Head of Process Sciences, Manufacturing and Supply Chain /s/ Michael D. Mulholland, as attorney-in-fact 2019-12-23